Favorable Results for Major Depressive Disorder Patients

Video

Antony Loebel, MD, Executive Vice President and Chief Medical Officer, Sunovion Pharmaceuticals Inc. provided invaluable insight on the first placebo-controlled trial for patients with Major Depressive Disorder with mixed features.

Antony Loebel, MD, Executive Vice President and Chief Medical Officer, Sunovion Pharmaceuticals Inc. provided invaluable insight on the first placebo-controlled trial for patients with Major Depressive Disorder with mixed features.

Related Videos
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Caroline Sisson, MMS, PA-C: Updates in Pulmonary Function Testing
Ali Rezaie, MD | Credit: X
Should We Reclassify Diabetes Subtypes?
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
Primary Care Roles in Alzheimer Diagnosis, with Theresa Sivers-Teixeira, MSPA, PA-C
© 2024 MJH Life Sciences

All rights reserved.